secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001372514-24-000002
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals receives Nasdaq extension to July 15, 2024 for bid price compliance
--------------------------------------------------------------------------------

- Nasdaq grants additional 180-day compliance period until July 15, 2024 for $1.00 minimum bid price rule.
- Company failed to regain compliance by original deadline of January 15, 2024; stock below $1 since July 2023.
- Extension conditioned on meeting market value of publicly held shares and other initial listing standards.
- Company evaluating reverse stock split to cure deficiency; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000002/0001372514-24-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000002/kprx-20240116.htm
  HTML page:      https://secwatch.observer/filing/0001372514-24-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer